Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
O-14 NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CORONARY HEART DISEASE
Máximo Cattaneo; Juan Pablo Roblero; Luis Vega; Marcelo Salinas; Andrea Urra; Daniela Simian; Rosario Pino; Álvaro Urzúa; Katherine Rojas; Juan Rozas; Abraham I Gajardo; Jaime Poniachik;
Ann Hepatol. 2023;28 Supl 1:
Association of sleep patterns and disorders with metabolic dysfunction-associated steatotic liver disease and liver fibrosis in contemporary American adults
Guannan Zong; Wangjia Mao; Ming Wen; Xiaoyun Cheng; Guanghui Liu;
10.1016/j.aohep.2024.101583
FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease
Mário Reis Álvares-da-Silva; Márcia da Silva Vargas; Soheyla Mohd Souza Rabie; Gabriella Jonko; Patricia Gabriela Riedel; Larisse Longo; Marcelo Rodrigues Gonçalves; Vivian Cristine Luft; Dvora Joveleviths;
10.1016/j.aohep.2024.101584